Daniel Wiznia, MD
Orthopaedic Surgery · New Haven, CTNPI 1740548023
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.7%), travel and lodging and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Globus Medical at 49.1% of the total.
Across 182 payments — averaging $241.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$22K
- Zimmer Biomet$11K
- Smith+Nephew$8K
- Intellijoint Surgical Inc.$2K
- Stryker$1K
- Biocomposites Inc$158
- plus $157 from 2 others
Across 5 payments — averaging $10,687 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$43K
- Stryker$8K
- Synthes USA Products LLC$2K
Across 1 payment — averaging $87.00 each. An ownership or investment interest held by the physician or an immediate family member.
- Intellijoint Surgical Inc.$87
What the payments were for
- Consulting fees$17,00039%
- Speaking & faculty fees$3,4008%
- Travel & lodging$11,58126%
- Food & beverage$4,39210%
- Education$7,51717%
- Gifts$710%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 31 | $21,579 |
| Zimmer Biomet | 114 | $10,843 |
| Smith+Nephew | 9 | $8,402 |
| Intellijoint Surgical Inc. | 3 | $1,750 |
| Stryker | 19 | $1,074 |
| Biocomposites Inc | 3 | $158 |
| Conformis, Inc. | 2 | $133 |
| Maxx Orthopedics, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Genflex2 Total Knee System$10,450
- Legacy Stelkast Knee$5,988
- Persona$2,893
- Hips-None$1,772
- Intellijoint HIP$1,750
- Surgical Product Portfolio$1,663
- ACTIFY 3D$1,657
- Cementless Knee$1,169
- Minority Initiatives-None$829
- Total Knee Arthroplasty$638
- Actify$523
- Surgical-None$487
- Taperloc$309
- MAKO$305
- Joint Arthoplasty$286
- Legion$201
- Navio Surgical System$201
- VISIONAIRE FastPak$201
- ZUK Uni$201
- INSIGNIA$130
How this compares
$43,962 in reported general payments places this provider in the 85th percentile of 273 orthopaedic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 15 | $319 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Haven
- Peter WhangNew Haven$1.8M
- David FrumbergNew Haven$288K
- Michael LeslieNew Haven$85K
- Lee RubinNew Haven$72K
- John FulkersonNew Haven$67K
- Kristaps KeggiNew Haven$52K
- Dominick TuasonNew Haven$40K
- Ilda MolloyNew Haven$37K
- Michael MedveckyNew Haven$33K
- Francis LeeNew Haven$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.